The Single-Dose Application of Interleukin-4 Ameliorates Secondary Brain Damage in the Early Phase after Moderate Experimental Traumatic Brain Injury in Mice

Activation of the interleukin-4 (IL-4) pathway ameliorates secondary injury mechanisms after experimental traumatic brain injury (TBI); therefore, we assessed the effect of a therapeutic IL-4 administration on secondary brain damage after experimental TBI. We subjected 100 C57/Bl6 wildtype mice to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Johannes, Mende, Jannis, Hutagalung, Samuel, Alhalabi, Obada T., Grutza, Martin, Zheng, Guoli, Skutella, Thomas, Unterberg, Andreas, Zweckberger, Klaus, Younsi, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454634/
https://www.ncbi.nlm.nih.gov/pubmed/37628939
http://dx.doi.org/10.3390/ijms241612756

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454634/
https://www.ncbi.nlm.nih.gov/pubmed/37628939
http://dx.doi.org/10.3390/ijms241612756

Ejemplares similares